140 related articles for article (PubMed ID: 38382534)
1. Gaillardin exerts potent antileukemic effects on HL-60 cells and intensifies arsenic trioxide cytotoxicity: Providing new insight into sesquiterpene lactones in leukaemia treatment.
Noormohamadi H; Hamzeloo-Moghadam M; Bashash D; Kargar M; Izadirad M; Hasanpour SZ; Gharehbaghian A
Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13847. PubMed ID: 38382534
[TBL] [Abstract][Full Text] [Related]
2. Gaillardin, a potent sesquiterpene lactone induces apoptosis via down-regulation of NF-κβ in gastric cancer cells, AGS and MKN45.
Roozbehani M; Abdolmohammadi MH; Hamzeloo-Moghadam M; Irani S; Fallahian F
J Ethnopharmacol; 2021 Dec; 281():114529. PubMed ID: 34418511
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of apoptosis induction by Gaillardin, a sesquiterpene lactone, in breast cancer cell lines : Gaillardin-induced apoptosis in breast cancer cell lines.
Fallahian F; Aghaei M; Abdolmohammadi MH; Hamzeloo-Moghadam M
Cell Biol Toxicol; 2015 Dec; 31(6):295-305. PubMed ID: 26843455
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative Effect of Gaillardin from
Karami A; Hamzeloo-Moghadam M; Yami A; Barzegar M; Mashati P; Gharehbaghian A
Nutr Cancer; 2020; 72(6):1043-1056. PubMed ID: 31544515
[TBL] [Abstract][Full Text] [Related]
5. Effects of co-administration of arsenic trioxide and Schiff base oxovanadium complex on the induction of apoptosis in acute promyelocytic leukemia cells.
Mirjalili S; Khaleghian A; Kalalinia F
Biometals; 2021 Oct; 34(5):1067-1080. PubMed ID: 34255251
[TBL] [Abstract][Full Text] [Related]
6. Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment.
Yedjou CG; Moore P; Tchounwou PB
Int J Environ Res Public Health; 2006 Jun; 3(2):136-40. PubMed ID: 16823087
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic activity and apoptosis induction by gaillardin.
Moghadam MH; Naghibi F; Atoofi A; Rezaie MA; Irani M; Mosaddegh M
Z Naturforsch C J Biosci; 2013; 68(3-4):108-12. PubMed ID: 23819305
[TBL] [Abstract][Full Text] [Related]
8. Gaillardin inhibits autophagy and induces apoptosis in MCF-7 breast cancer cells by regulating JAK/STAT pathway.
Rajabi S; Tahmasvand Z; Maresca M; Hamzeloo-Moghadam M
Mol Biol Rep; 2024 Jan; 51(1):158. PubMed ID: 38252203
[TBL] [Abstract][Full Text] [Related]
9. Ergolide, a potent sesquiterpene lactone induces cell cycle arrest along with ROS-dependent apoptosis and potentiates vincristine cytotoxicity in ALL cell lines.
Yami A; Hamzeloo-Moghadam M; Darbandi A; Karami A; Mashati P; Takhviji V; Gharehbaghian A
J Ethnopharmacol; 2020 May; 253():112504. PubMed ID: 31904493
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
Leu L; Mohassel L
Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784
[TBL] [Abstract][Full Text] [Related]
11. Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide.
Borges GSM; Sicard P; de Mello Gomides Loures C; Evangelista FGC; Sales CC; de Paula Sabino A; Fernandes C; Ferreira LAM; Richard S
AAPS PharmSciTech; 2023 Mar; 24(3):79. PubMed ID: 36918482
[TBL] [Abstract][Full Text] [Related]
12. Sesquiterpene lactones from Inula oculus-christi.
Mosaddegh M; Moghadam MH; Ghafari S; Naghibi F; Ostad SN; Read RW
Nat Prod Commun; 2010 Apr; 5(4):511-4. PubMed ID: 20433061
[TBL] [Abstract][Full Text] [Related]
13. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells.
Sturlan S; Baumgartner M; Roth E; Bachleitner-Hofmann T
Blood; 2003 Jun; 101(12):4990-7. PubMed ID: 12609832
[TBL] [Abstract][Full Text] [Related]
15. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells.
Yedjou C; Tchounwou P; Jenkins J; McMurray R
J Hematol Oncol; 2010 Aug; 3():28. PubMed ID: 20796291
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells.
Kumar S; Yedjou CG; Tchounwou PB
J Exp Clin Cancer Res; 2014 May; 33(1):42. PubMed ID: 24887205
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
Huan SY; Yang CH; Chen YC
Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
20. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
Huang X
Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
